Section 1503, [Pub. L. 100–690, title I, § 1004], Nov. 18, 1988, [102 Stat. 4184], related to coordination between Office of National Drug Control Policy and executive branch departments and agencies. See [section 1704 of this title].
Section 1504, [Pub. L. 100–690, title I, § 1005], Nov. 18, 1988, [102 Stat. 4185]; [Pub. L. 103–322, title IX, § 90203], Sept. 13, 1994, [108 Stat. 1991]; [Pub. L. 105–20, § 2(b)], June 27, 1997, [111 Stat. 234], related to annual development and submission of National Drug Control Strategy by President to Congress. See [section 1705 of this title].
Section 1505, [Pub. L. 100–690, title I, § 1008], formerly § 1003A, as added [Pub. L. 101–510, div. A, title X, § 1011], Nov. 5, 1990, [104 Stat. 1633]; renumbered § 1008 and amended [Pub. L. 103–322, title IX, § 90204(a)], (b), (c)(2), (3), Sept. 13, 1994, [108 Stat. 1993], 1994, established Counter-Drug Technology Assessment Center within Office of National Drug Control Policy.
A prior section 1505, [Pub. L. 100–690, title I, § 1008], Nov. 18, 1988, [102 Stat. 4188], provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by [Pub. L. 103–322, § 90204(c)(1)].
Statutory Notes and Related Subsidiaries
Effective Date of RepealRepeal effective Sept. 30, 1997, see [section 1009 of Pub. L. 100–690], as amended, which was formerly classified to [section 1506 of this title].